Red blood cell metabolic enzyme

Red blood cell metabolic enzymes are a group of intracellular enzymes essential for the maintenance, function, and survival of erythrocytes. These enzymes control several key metabolic pathways, primarily glycolysis and the pentose phosphate pathway (hexose monophosphate shunt), which together allow red blood cells (RBCs) to produce ATP for membrane ion gradients and NAD(P)H to counteract oxidative stress[1][2]. Major enzymes include glucose-6-phosphate dehydrogenase (G6PD), hexokinase, phosphoglucose isomerase, aldolase, pyruvate kinase, and triosephosphate isomerase, among others. Deficiencies or mutations in these enzymes commonly cause hereditary hemolytic anemias, since energy and redox homeostasis are critical for RBC viability[2][1]. Abnormal enzyme activity leads to increased RBC fragility, hemolysis, and subsequent anemia, and can also make RBCs less able to cope with oxidative or metabolic stress, for example, during certain infections, exposure to particular drugs, or rapid cell turnover[1]. In addition to glycolysis and the pentose phosphate pathway, these enzymes are also involved in specialized RBC metabolic processes such as the Rapoport–Luebering shunt, which controls oxygen release from hemoglobin through 2,3-diphosphoglycerate, and in redox chemistry to maintain hemoglobin iron in its functional reduced state[1]. Note: "Red blood cell metabolic enzymes" refers to a large group rather than a single target and should be subclassified for drug development or biomarker studies. If the intended query is for a specific enzyme (e.g., "Glucose-6-phosphate dehydrogenase" or "Pyruvate kinase"), more specific structured information should be requested.

Other names

Red blood cell enzymeerythrocyte enzymeRBC metabolic enzyme

Alteration of red cell metabolism (inhibition or supplementation of enzyme function); Drug-induced oxidative stress (causes hemolysis in enzyme-deficient individuals)